Dr Alhaq is has been a peer reviewer for the United Kingdom & Belgium Accreditation Services for medical laboratory services and a past reviewer of the Healthcare Inspectorate Wales. As an academic researcher, he was a principal investigator and senior lecturer at KCL, London from 2002-2012 and a visiting senior lecturer at Kingston University, helping to set up and teach on the MSc programme on Cancer Studies.

Dr Alhaq is a Clinical Medical Advisor to the African Export-Import Bank (Afreximbank), leading the Bank’s strategy of developing a chain of African Medical Centres of Excellence (AMCE) focusing on delivering tertiary referral centres. He is a non-executive director of the first AMCE in Abuja, Nigeria, focusing on cancer, cardiovascular disease, and haematological medicine.

Dr Alhaq served as Chief Clinical Scientist at King’s College Hospital from 2016-2022 and was a non-executive director of Viapath Pathology from 2012-2018. At an operational role, he has held several divisional roles within KingsPath and Viapath pathology services and was an operational lead and board member of the South-East pathology Transformation Programme from 2018-2021. He was operational lead for the 100,000 Genomes project at King’s College Hospital from 2014-2018. During the COVID-19 pandemic, he was seconded to the NHS Test & Trace programme to help expand the SARS-CoV2 PCR testing capacity both locally and nationally, and to establish a robust framework for validating new SARS-CoV2 testing.

Hatim is Chief Executive Officer for Health Innovation Kent Surrey Sussex, part of the NHS Health Innovation Network. Alongside this role, he continues to practice as a General Practitioner.

In 2018, Hatim was appointed National Medical Directors Clinical Fellow to Professor Wendy Reid by the Faculty of Medical Leadership and Management. His key achievements were co-author and member of the Sir Keith Pearson Commission into NHS Staff and Learner Mental Health and co-founding the ‘Topol Programme for Digital Health Fellowships’ launched by Secretary of State for Health and Social Care in 2019.

He later became the National Clinical Lead for AI and Digital Workforce at NHS England providing clinical leadership to the NHS Digital Academy and leading on AI in the NHS’s historic Long Term Workforce Plan.

Michael co-leads The Centre for Translational Bioinformatics (C4TB), at Queen Mary University of London and is a Fellow of the Digitial Environment Research Institute, QMUL. His team work across diverse research areas, including genomics, drug discovery, stratified medicine, machine learning and health informatics with a unified objective to drive forward translation into the clinic. He brings an industrial perspective to the C4TB, drawn from 16 years of leadership of bioinformatics teams in the pharmaceutical industry. 

Michael is a Fellow of the Alan Turing Institute and an HDR-UK Investigator, and co-leads the Genomics England Stratified medicine genomic interpretation clinical partnership.

Dr Nicola Byrne has served as the National Data Guardian for health and adult social care in England since March 2021. With over 20 years of experience in mental health, she continues her clinical role as a consultant psychiatrist at South London and Maudsley NHS Foundation Trust. Previously, she held the positions of Deputy Medical Director, Caldicott Guardian, and Chief Clinical Information Officer at the trust.

The National Data Guardian offers independent advice, guidance, and challenge to the government and others on the safe, ethical, and appropriate use of people’s confidential information in health and adult social care. The role’s mission is to uphold trust in a confidential health and care system.

With over 30 years of midwifery experience, Jules Gudgeon is a key player in advancing digital technology in maternity care, post the 2015 National Maternity Review by Baroness Cumberlege. Leading roles in the NHS Digital Maternity Programme and the creation of the award-winning Digital Midwives Expert Reference Group, now the Digital Maternity Leaders community, showcases her commitment to collaborative efforts in the digital maternity landscape.

As the National Chief Midwifery Information Officer at NHS England, she was a 2023 HSJ Clinical Leader of the Year Award finalist. In 2024, Jules persists in advocating for digital leadership and addressing the maternity digital divide with #FixTheDigitalDivide #DigitalMaternity.

Achievements of note include: founding the UK CCIO movement, from launch of CCIO campaign in 2011 to development and growth of CCIO Networks and community; the development of Digital Health Networks – centred on CCIO and CIO Networks – as the leading independent online best practice community of NHS IT professionals – 5,000+ members as of November 2020; plus growing Digital Health Summer Schools into the premier health IT leadership event in UK; and launching Digital Health Rewired in March 2019 as the most dynamic and compelling Expo in digital health space.

Zella developed a real-time application that is in daily use by the patient flow team at UCLH to predict demand for emergency beds, and is lead author on a paper about this work that has been published in Nature Digital Medicine. Her team at UCL won a London Higher Healthcare Partnership of the Year award for their work with UCLH, and were finalists for a HSJ Digital award in Improving Urgent and Emergency Care.

Professor David J Lowe is Clinical Director Innovation University of Glasgow, Emergency Consultant at Queen Elizabeth University Hospital, Glasgow and Clinical Lead for Health Innovation for Scottish Government. David has significant experience of creating the infrastructure and conditions to develop innovative devices, services and solutions with a range of industry and academic partners both UK and worldwide. He is clinical lead for a number of projects with DHVL and previously iCAIRD including ensemble based AI techniques for COVID, osteoporosis as well as supporting evaluation and development of AI solutions across a range of imaging modalities. He leads on range of projects including trauma for the STN (thetraumaapp.com), Dynamic COPD (support.nhscopd.scot) and OPERA(early diagnostic heart failure utilising AI). Such projects focus on developing AI/ML clinical decision support by embedding a data driven approach combined with patient co-management into clinical care pathways. David also established the EmQuire research group focusing on data, device and decisions within Emergency Medicine.

She is equally leading efforts to facilitate secure access to data for research and innovation with the design and implementation of a network-wide approach to data management and governance.

Haris Shuaib is CEO of Newton’s Tree, a company that delivers an enterprise AI platform to healthcare organisations to help them evaluate, deploy, and monitor 3rd party AI solutions.

Haris is also a healthcare professional and currently Consultant Clinical Scientist and Head of the Clinical Scientific Computing section at Guy’s & St Thomas’ NHS Foundation Trust, where his team are developing people, platforms, and policy for digital health.
Finally, he also holds a NIHR Doctoral Research Fellowship, where he is leading a national multi-centre trial to see whether AI can improve the treatment of glioblastoma.

Ming has over 20 years’ experience in managing and delivering large scale change involving implementation of new operating models in complex and challenging environments.

She joined the NHS in October 2009, initially leading commissioning support services in the West Midlands as the Managing Director for Healthcare Commissioning Services and then as the Managing Director for South Yorkshire and Bassetlaw Commissioning Support Unit.

Ming is currently the Chief Data and Analytics Officer for NHS England responsible for strategic development of data and analytics capability across NHS.

Dr Lauren Walker is Clinical Senior Lecturer in Clinical Pharmacology & Therapeutics and Honorary Consultant in General Internal Medicine. She co-leads the DynAIRx programme, funded by the NIHR AI in multimorbidity stream and her research interest involves utilising existing health record data to understand how multiple long-term conditions, and their associated prescriptions, evolve over time and how these relationships between drugs and diseases lead to harm.

She is very interested in predicting risk and examining patient journeys to identify at what point the harm of a medicine outweighs the potential for benefit. She contributes to outpatient clinics, inpatient reviews and multidisciplinary team meetings for adults with complex multimorbidity & polypharmacy.